Kymriah (tisagenlecleucel; Novartis) Overview 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Kymriah” report has been added to ResearchAndMarkets.com’s offering. Kymriah (tisagenlecleucel; Novartis) is a cluster of differentiation (CD)19-targeted genetically…